Galapagos Nv Revenue per Employee (GLPG), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Galapagos Nv  (NASDAQ: GLPG)
 

Galapagos Nv's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


Galapagos Nv's Revenue per employee fell on a trailing twelve month basis to $ 3,412,925, but the productivity of Galapagos Nv's employees remained above the company average.
Within the Healthcare sector Employees of 19 other companies have achieved higher revenue per employee. While Galapagos Nv's total ranking has deteriorated compared to the previous quarter from 0 to 329. Galapagos Nv has 365 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

GLPG Revenue per Employee (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2024)
IV. Quarter
Y / Y Revenue Change 303.5 % - - - 14.99 %
Sales per Employee (TTM) $ 3,412,925 845,827 845,827 845,827 845,827
GLPG's Total Ranking # 329 # 0 # # #
Seq. Revenue Change - - - - -

GLPG Company Profile >> Back to GLPG Efficiency Comparisons >> Compare GLPG Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 11
Healthcare Sector # 20
Overall Market # 329

Revenue per Employee Statistics
High Average Low
$ 3,412,925 $ 1,540,539 $ 735,591
(Dec 31 2025)   (Dec 31 2023)



Financial Statements
Galapagos Nv's Revenue MRQ $ 1,246 Millions Visit GLPG's Income Statement
Galapagos Nv's Revenues TTM $ 1,246 Millions Visit GLPG's aggregate revenue growth
What are GLPG's Sales? Visit GLPG's Sales by Segment




Other Ratios
Galapagos Nv's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
GLPG's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for GLPG's Competitors
Revenue per Employee for GLPG's Suppliers
Revenue per Employee for GLPG's Customers

You may also want to know
GLPG's Sales Growth Rates GLPG's Pe Price to earnings ratio GLPG's Receivables Turnover Ratio GLPG's Stock Quote
GLPG's Net Income Growth Rates GLPG's Ps Price to Sales ratio GLPG's Sales per Employee GLPG's Asset Turnover Ratio
GLPG's Net Margin GLPG's Pb Price to Book ratio GLPG's Financial Strength Ratios GLPG's Dividend Payout Ratio
Date modified: 2026-07-07T11:24:58+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2025, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2025Number of Employees Dec 31 2025
Ligand Pharmaceuticals Incorporated  5,703,978.72 $ 268.087  Million 47 
Anika Therapeutics Inc   5,371,761.90 $ 112.807  Million 21 
P3 Health Partners Inc   4,559,625.00 $ 1,459.080  Million 320 
Xeris Biopharma Holdings Inc   4,489,923.08 $ 291.845  Million 65 
Novo Nordisk A  4,446,644.13 $ 309,064.000  Million 69,505 
Community Health Systems Inc   4,027,419.35 $ 12,485.000  Million 3,100 
Aytu Biopharma Inc  3,866,875.00 $ 61.870  Million 16 
Xoma Royalty Corporation  3,724,928.57 $ 52.149  Million 14 
Vaxart Inc   3,650,123.08 $ 237.258  Million 65 
Compugen Ltd  3,464,952.38 $ 72.764  Million 21 
Amgen Inc   3,453,846.15 $ 44,900.000  Million 13,000 
Galapagos Nv  3,412,925.37 $ 1,245.718  Million 365 
Illumina Inc   3,392,968.75 $ 4,343.000  Million 1,280 
Keros Therapeutics Inc   3,304,948.72 $ 257.786  Million 78 
Halozyme Therapeutics Inc   3,301,680.85 $ 1,396.611  Million 423 
Catalyst Pharmaceuticals Inc   3,236,203.30 $ 588.989  Million 182 
Therapeuticsmd Inc   3,022,000.00 $ 3.022  Million 1 
Harmony Biosciences Holdings inc   2,962,836.18 $ 868.111  Million 293 
Ironwood Pharmaceuticals inc   2,961,510.00 $ 296.151  Million 100 
Spero Therapeutics Inc   2,672,080.00 $ 66.802  Million 25 
Sarepta Therapeutics Inc   2,632,619.16 $ 2,198.237  Million 835 
Grifols Sa  2,622,745.10 $ 8,426.880  Million 3,213 
Innoviva Inc   2,419,289.31 $ 384.667  Million 159 
United Therapeutics Corporation  2,273,357.14 $ 3,182.700  Million 1,400 
Anaptysbio Inc   2,255,798.08 $ 234.603  Million 104 
Assertio Holdings inc   2,239,867.92 $ 118.713  Million 53 
Aurinia Pharmaceuticals Inc   2,211,367.19 $ 283.055  Million 128 
Elite Pharmaceuticals Inc   2,131,496.71 $ 138.547  Million 65 
Exelixis Inc   2,022,777.68 $ 2,320.126  Million 1,147 
Biocryst Pharmaceuticals Inc   2,011,119.54 $ 874.837  Million 435 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.